AbbVie Seals $54B Shire Takeover In Major Inversion Deal
AbbVie Inc. sealed its contentious tax-motivated play for British drugmaker Shire PLC as the companies said Friday that AbbVie would buy its rival in a cash-and-stock deal valuing Shire at £31.35...To view the full article, register now.
Already a subscriber? Click here to view full article